|
Theresa Deisher PhD
|
|
Founder & CEO AVM Biotechnology |
Bio
Theresa A. Deisher, Ph.D. graduated from Stanford University School of Medicine with a doctoral degree in Molecular & Cellular Physiology. She has over 40 issued US/EU/JP patents and discoveries in clinic (Sprifermin Ph III, Factor XIII Ph II). She has had extensive scientific and management experience in the commercial biotechnology field including Genentech, Repligen, ZymoGenetics, Immunex/Amgen.
Sessions
Where Do Stem Cells End Up and How We Can Improve the Results?
Thursday, October 24, 2019
4:15 PM - 4:45 PM
Location: Colorado DE
Disclosure Information
As of October 11, 2019 04:12:31 PM
- AVM Biotechnology - Public Stock Shareholder;
